BioCentury | Mar 17, 2021
Politics, Policy & Law
CMS drops plan to erode Medicare Part D protections, retains generic, biosimilar incentives
...forward with a policy allowing Part D beneficiaries to spread drug costs over a year.
Steve Usdin
Centers for Medicare & Medicaid Services
Medicare
biosimilars...